Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Each study has a usefulness score out of 100 (rubric version 4.0). Tap a score to see what makes it up.

Highest usefulness score first. Studies without a score come last.

  1. Dysfunction of NMDA receptors in Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2016-03-12 Disease mechanisms

    N-methyl-D-aspartate receptors (NMDARs) play a pivotal role in the synaptic transmission and synaptic plasticity thought to underlie learning and memory.

  2. The role of calsyntenin-3 in dystrophic neurite formation in Alzheimer's disease brain

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. Geriatrics & gerontology international 2016-03 Disease mechanisms

    β-Amyloid (Aβ) oligomers may play an important role in the early pathogenesis of Alzheimer's disease: cognitive impairment caused by synaptic dysfunction.

  3. Emerging Link between Alzheimer's Disease and Homeostatic Synaptic Plasticity

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. Neural plasticity 2016-02-25 Disease mechanisms

    Alzheimer's disease (AD) is an irreversible brain disorder characterized by progressive cognitive decline and neurodegeneration of brain regions that are crucial for learning and memory.

  4. Tau-directed approaches for the treatment of Alzheimer's disease: focus on leuco-methylthioninium

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. Expert review of neurotherapeutics 2016 Drug development

    Small molecular weight compounds able to inhibit formation of tau oligomers and fibrils have already been tested for Alzheimer's disease (AD) treatment.

  5. Unfolded Protein Response and Macroautophagy in Alzheimer's, Parkinson's and Prion Diseases

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. Molecules (Basel, Switzerland) 2015-12-18 Disease mechanisms

    Proteostasis are integrated biological pathways within cells that control synthesis, folding, trafficking and degradation of proteins.

  6. Tau Immunotherapy

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. Neuro-degenerative diseases 2015-11-10 Drug development

    In recent years, tau immunotherapy has advanced from proof-of-concept studies [Sigurdsson EM, NIH R01AG020197, 2001; Asuni AA, et al: J Neurosci 2007;27:9115-9129], which have now been confirmed and extended by us and others.

  7. Imaging β-amyloid using [(18)F]flutemetamol positron emission tomography: from dosimetry to clinical diagnosis

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. European journal of nuclear medicine and molecular imaging 2015-10-06 Brain scans and imaging

    In Alzheimer's disease (AD), the deposition of β-amyloid (Aβ) is hypothesized to result in a series of secondary neurodegenerative processes, leading ultimately to synaptic dysfunction and neuronal loss.

  8. TDP-43 in amyotrophic lateral sclerosis - is it a prion disease?

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. European journal of neurology 2015-05 Brain tissue and pathology

    Amyotrophic lateral sclerosis is a devastating disease characterized by rapidly progressive paresis.

  9. Neuronal pentraxin 1 negatively regulates excitatory synapse density and synaptic plasticity

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. The Journal of neuroscience : the official journal of the Society for Neuroscience 2015-04-08 Disease mechanisms

    In mature neurons, the number of synapses is determined by a neuronal activity-dependent dynamic equilibrium between positive and negative regulatory factors.

  10. Synaptic dysfunction and septin protein family members in neurodegenerative diseases

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. Molecular neurodegeneration 2015-04-03 Disease mechanisms

    Cognitive decline and disease progression in different neurodegenerative diseases typically involves synaptic dysfunction preceding the neuronal loss.

  11. Cleavage of amyloid precursor protein by an archaeal presenilin homologue PSH

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. Proceedings of the National Academy of Sciences of the United States of America 2015-03-02 Biomarkers

    Aberrant cleavage of amyloid precursor protein (APP) by γ-secretase contributes to the development of Alzheimer's disease.

  12. Tau Positron Emission Tomography (PET) Imaging: Past, Present, and Future

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. Journal of medicinal chemistry 2015-02-25 Brain scans and imaging

    Alzheimer's disease (AD) is a chronic neurodegenerative disorder and the most common cause of dementia among the elderly population.

  13. The Ubiquitin-Proteasome System and Molecular Chaperone Deregulation in Alzheimer's Disease

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. Molecular neurobiology 2015-01-07 Disease mechanisms

    One of the shared hallmarks of neurodegenerative diseases is the accumulation of misfolded proteins.

  14. Regulating extracellular proteostasis capacity through the unfolded protein response

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. Prion 2015 Disease mechanisms

    The extracellular aggregation of proteins into proteotoxic oligomers and amyloid fibrils is implicated in the onset and pathology of numerous diseases referred to as amyloid diseases.

  15. Autophagy of mitochondria: a promising therapeutic target for neurodegenerative disease

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. Cell biochemistry and biophysics 2014-11 Disease mechanisms

    The autophagic process is the only known mechanism for mitochondrial turnover and it has been speculated that dysfunction of autophagy may result in mitochondrial error and cellular stress.

  16. Pharmacological inhibition of BACE1 impairs synaptic plasticity and cognitive functions

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. Biological psychiatry 2014-10-29 Disease mechanisms

    Dose-dependent decrease of Aβ40 levels in vivo confirmed suppression of BACE1 activity by both inhibitors.

  17. Synaptic Plasticity and Memory: New Insights from Hippocampal Left-Right Asymmetries

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry 2014-09-19 Disease mechanisms

    All synapses are not the same. They differ in their morphology, molecular constituents, and malleability.

  18. Correlation between decreased CSF α-synuclein and Aβ₁₋₄₂ in Parkinson disease

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. Neurobiology of aging 2014-08-04 Tau biomarkers

    Accumulation of misfolded α-synuclein (α-syn) protein in Lewy bodies and neurites is the cardinal pathologic feature of Parkinson disease (PD), but abnormal deposition of other proteins may also play a role.

  19. Cerium oxide nanoparticle: a remarkably versatile rare earth nanomaterial for biological applications

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. NPG Asia Materials 2014-03-01 Risk factors

    Cerium oxide nanoparticles (CeONPs) have attracted much attention because they possess multi-enzyme mimetic properties and have been used in bioanalysis, biomedicine, drug delivery, bioscaffold and so on.

  20. The ubiquitin-proteasome system in neurodegeneration

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. Antioxidants & redox signaling 2014-02-27 Disease mechanisms

    Impairment of the ubiquitin-proteasome system (UPS) has been implicated in the pathogenesis of a wide variety of neurodegenerative disorders, including Alzheimer's, Parkinson's, and Huntington's diseases.

  21. Lysosome and calcium dysregulation in Alzheimer's disease: partners in crime

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. Biochemical Society transactions 2013-12 Risk genes beyond APOE

    Early-onset FAD (familial Alzheimer's disease) is caused by mutations of PS1 (presenilin 1), PS2 (presenilin 2) and APP (amyloid precursor protein).

  22. Tau immunotherapy and imaging

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. Neuro-degenerative diseases 2013-09-11 Drug development

    Disappointing findings from recent phase III trials on amyloid-β (Aβ) immunotherapy for Alzheimer's disease (AD) have shifted the focus of such treatments to the tau protein.

  23. Efficient in vivo delivery of antisense oligonucleotide to choroid plexus

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. Journal of medical and dental sciences 2013-03-01 Drug development

    The choroid plexus (CP) is present on the ventricular walls of the brain, produces cerebrospinal fluid (CSF), contains many blood vessels, and is a major functional component of the blood-CSF barrier.

  24. The role of neuronal calcium sensors in balancing synaptic plasticity and synaptic dysfunction

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. Frontiers in molecular neuroscience 2012-05-04 Disease mechanisms

    Neuronal calcium sensors (NCS) readily bind calcium and undergo conformational changes enabling them to interact and regulate specific target molecules.

  25. Autophagy in dementias

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. Brain pathology (Zurich, Switzerland) 2012-01 Disease mechanisms

    Dementias are a varied group of disorders typically associated with memory loss, impaired judgment and/or language and by symptoms affecting other cognitive and social abilities to a degree that interferes with daily functioning.

From across this topic

10 of the 1,352 studies in this topic, picked by a fixed rule (a hash of each study's address), not by score or date; each page of this list shows a different 10. The same 10 appear here every time.

Other topics